Description
Generate Biomedicines is at the forefront of a new era in therapeutics, existing at the intersection of biology, machine learning, and biological engineering. The company is pioneering a revolutionary approach known as Generative Biology, which allows for the programming of protein-based modalities. This innovative method is made possible through the integration of various scientific disciplines, enabling the creation of breakthrough medicines.
The Generate Platform is a key component of their approach, moving beyond traditional trial-and-error methods in drug development. It infers generalizable principles of biology from large-scale observations to deliberately generate medicines aimed at treating some of humanity's most intractable diseases. This platform represents a fundamental shift in therapeutic development, allowing for the rapid identification and validation of therapeutics.
Generate Biomedicines has studied millions of proteins to learn the rules by which nature encodes function. These rules are used to generate novel medicines with specific therapeutic functions. The platform can create medicines on demand across multiple therapeutic modalities with unprecedented speed and success rates.
Their machine learning models are capable of generating protein complexes, including antibodies that target specific epitopes and functional antibodies that agonize cell surface receptors. This capability extends to optimizing protein properties such as enzymes with increased processivity and specificity.
An example of their work is GB-0895, a therapeutic designed to block TSLP, a key initiator of the inflammatory cascade in asthma. This drug has been co-optimized for biological effect and patient experience, with the potential to shift treatment from monthly to just twice per year.
Generate Biomedicines is committed to pushing boundaries in drug development, working across disciplines to advance ideas and science together. Their efforts are supported by a dedicated team and state-of-the-art facilities, including over 140,000 square feet of space in their Boynton Yards and Andover locations.
Generate Biomedicines's Core Features
Generative Biology for drug development
The Generate Platform for rapid therapeutic creation
Machine learning-driven protein design
On-demand medicine creation
Optimization of protein properties
Development of immune-invisible proteins
Continuous feedback loop in drug discovery
Cross-disciplinary scientific integration
How to use Generate Biomedicines?
Explore: Learn about Generative Biology
Understand: Study the Generate Platform
Collaborate: Work with cross-disciplinary teams
Innovate: Develop novel protein-based therapies
Generate Biomedicines's Use Cases
- Drug Discovery
- Protein Optimization
- Immune-Invisible Proteins
- Therapeutic Development
- Cross-Disciplinary Collaboration
